百欧海文制药 BHVN
$14.48 +$0.58 (+4.17%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.58 +0.69%
开盘$14.23
昨收$13.90
当日区间$13.76 – $14.50
成交量2.92M
市值$2.19B
市盈率（TTM）–
股息率–
BHVN 相关新闻
匹配 Biohaven 或代码 BHVN 的头条新闻，按最新排序。
- RBC Capital Downgrades Biohaven(BHVN.US) to Hold Rating, Cuts Target Price to $19 负面
- CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $21
- Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
- Citi Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $17
- Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Boston Scientific (BSX) 正面
- J.P. Morgan Maintains Biohaven(BHVN.US) With Buy Rating
- Raymond James Maintains Biohaven(BHVN.US) With Buy Rating
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
- William Blair Maintains Biohaven(BHVN.US) With Hold Rating
- Analysts Are Bullish on These Healthcare Stocks: Globus Medical (GMED), Biohaven Ltd. (BHVN) 正面
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)
- BofA Securities Maintains Biohaven(BHVN.US) With Sell Rating, Maintains Target Price $11
- Analysts' Top Healthcare Picks: Molina Healthcare (MOH), Biohaven Ltd. (BHVN)
- Raymond James Maintains Biohaven(BHVN.US) With Buy Rating, Announces Target Price $30
- Piper Sandler Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $30
暂无评论——快来第一个聊聊 BHVN。
登录后参与讨论。